| View |
|
DRP-12207-02
|
Risperidone
|
Argixone-ODT
|
2 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 June 2024
|
29 June 2027
|
| View |
|
DRP-12412-10
|
Losartan Potassium
|
Lozarmel
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
23 June 2024
|
03 August 2025
|
| View |
|
DRP-12423-02
|
Anagrelide (as hydrochloride)
|
Anagrebene
|
500 mcg
|
Tablet
|
Antineoplastic Agent
|
Indeus Life Sciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 June 2024
|
04 August 2027
|
| View |
|
DRP-12598-04
|
Palonosetron (as hydrochloride)
|
Qualitron
|
50 mcg / mL (250 mcg/5 mL)
|
Solution for Injection (IV)
|
Antiemetic / Antinauseant [Serotonin (5HT3) Antagonist]
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
16 June 2024
|
12 September 2027
|
| View |
|
DRP-12702-05
|
Rosuvastatin (as Calcium)
|
Presuvas
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
PharmEvo (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
19 June 2024
|
11 May 2025
|
| View |
|
DRP-12735-08
|
Telmisartan + Amlodipine (as besilate)
|
Zamplify 80/10
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
30 September 2027
|
| View |
|
DRP-12737-07
|
Telmisartan + Amlodipine (as besilate)
|
Zamplify 80/5
|
80 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
30 September 2027
|
| View |
|
DRP-12770-01
|
Tranexamic acid
|
Actranex
|
500 mg
|
Film-Coated Tablet
|
Antifibrinolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
06 October 2027
|
| View |
|
DRP-12901-02
|
Amlodipine (as besilate)
|
Novalife 10
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
27 October 2027
|
| View |
|
DRP-13085-02
|
Febuxostat
|
Jiaastat-80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
30 June 2024
|
28 November 2027
|
| View |
|
DRP-13086-03
|
Febuxostat
|
Jiaastat-40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
28 November 2027
|
| View |
|
DRP-13127-10
|
Ketoanalogues + Essential Amino Acids
|
K-Mino
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 June 2024
|
05 December 2027
|
| View |
|
DRP-13194-02
|
Ondansetron (as hydrochloride dihydrate)
|
Kodasetron
|
2 mg/mL
|
Solution for Injection (I.V./I.M.)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Antagonist]
|
|
|
-
|
24 June 2024
|
22 December 2027
|
| View |
|
DRP-13171-10
|
Losartan Potassium + Amlodipine (as besilate)
|
Lozend Plus
|
50 mg/ 5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Calcium Channel Blocker (Dihydropyridine derivative)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 June 2024
|
14 December 2027
|
| View |
|
DRP-13209-06
|
Pregabalin
|
Retabaline
|
75 mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 June 2024
|
29 December 2027
|
| View |
|
DRP-13222-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazipro
|
4g/500mg
|
Powder for Injection (IV)
|
Antibacterial
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
26 March 2025
|
| View |
|
DRP-13229-13
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Su-Low
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
05 January 2028
|
| View |
|
DRP-13425-01
|
Citicoline
|
Aecoline
|
250 mg/mL (1 g/4 mL)
|
Solution for Injection (IV/IM)
|
Other Psychostimulants and Nootropics
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
31 March 2027
|
| View |
|
DRP-13483-01
|
Duloxetine (as hydrochloride)
|
Joytor-60
|
60 mg
|
Delayed Release Capsule
|
Antidepressant
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 June 2024
|
27 February 2028
|
| View |
|
DRP-13517-3
|
Levetiracetam
|
Kepdin
|
500 mg
|
Film-Coated Tablet
|
Anticonvulsant
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 June 2024
|
03 March 2028
|